Terms: = Leukemia AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP
411 results:
1. [Curcumin Combined with Thalidomide Inhibits Proliferation of KG-1 Cells and Its Related Mechanisms].
Liu J; Huang Y; Liu Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):422-427. PubMed ID: 38660846
[TBL] [Abstract] [Full Text] [Related]
2. BRCC36 associates with FLT3-ITD to regulate its protein stability and intracellular signaling in acute myeloid leukemia.
Liu J; Isaji T; Komatsu S; Sun Y; Xu X; Fukuda T; Fujimura T; Takahashi S; Gu J
Cancer Sci; 2024 Apr; 115(4):1196-1208. PubMed ID: 38288901
[TBL] [Abstract] [Full Text] [Related]
3. Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML.
Wheeler EC; Martin BJE; Doyle WC; Neaher S; Conway CA; Pitton CN; Gorelov RA; Donahue M; Jann JC; Abdel-Wahab O; Taylor J; Seiler M; Buonamici S; Pikman Y; Garcia JS; Belizaire R; Adelman K; Tothova Z
Sci Transl Med; 2024 Jan; 16(728):eade2774. PubMed ID: 38170787
[TBL] [Abstract] [Full Text] [Related]
4. RUNX1 mutations mitigate quiescence to promote transformation of hematopoietic progenitors in Fanconi anemia.
Marion W; Koppe T; Chen CC; Wang D; Frenis K; Fierstein S; Sensharma P; Aumais O; Peters M; Ruiz-Torres S; Chihanga T; Boettcher S; Shimamura A; Bauer DE; Schlaeger T; Wells SI; Ebert BL; Starczynowski D; da Rocha EL; Rowe RG
Leukemia; 2023 Aug; 37(8):1698-1708. PubMed ID: 37391485
[TBL] [Abstract] [Full Text] [Related]
5. Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination-Deficient leukemia Cells.
Sullivan-Reed K; Toma MM; Drzewiecka M; Nieborowska-Skorska M; Nejati R; Karami A; Wasik MA; Sliwinski T; Skorski T
Mol Cancer Res; 2023 Oct; 21(10):1017-1022. PubMed ID: 37358557
[TBL] [Abstract] [Full Text] [Related]
6. Oncogenic IDH mutations increase heterochromatin-related replication stress without impacting homologous recombination.
Schvartzman JM; Forsyth G; Walch H; Chatila W; Taglialatela A; Lee BJ; Zhu X; Gershik S; Cimino FV; Santella A; Menghrajani K; Ciccia A; Koche R; Sánchez-Vega F; Zha S; Thompson CB
Mol Cell; 2023 Jul; 83(13):2347-2356.e8. PubMed ID: 37311462
[TBL] [Abstract] [Full Text] [Related]
7. Unifying targeted therapy for leukemia in the era of PARP inhibition.
Boila LD; Sengupta A
Exp Hematol; 2023 Aug; 124():1-14. PubMed ID: 37236341
[TBL] [Abstract] [Full Text] [Related]
8. Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial.
Ray-Coquard I; Leary A; Pignata S; Cropet C; González-Martín A; Marth C; Nagao S; Vergote I; Colombo N; Mäenpää J; Selle F; Sehouli J; Lorusso D; Guerra Alia EM; Bogner G; Yoshida H; Lefeuvre-Plesse C; Buderath P; Mosconi AM; Lortholary A; Burges A; Medioni J; El-Balat A; Rodrigues M; Park-Simon TW; Dubot C; Denschlag D; You B; Pujade-Lauraine E; Harter P;
Ann Oncol; 2023 Aug; 34(8):681-692. PubMed ID: 37211045
[TBL] [Abstract] [Full Text] [Related]
9. iris and orbital myeloid sarcoma in a pediatric patient.
Qin VL; Verkuil L; Zanganeh T; Wertheim G; Davidson SL
J AAPOS; 2023 Jun; 27(3):157-160. PubMed ID: 37207926
[TBL] [Abstract] [Full Text] [Related]
10. Subcutaneous Microabscesses and Myositis as Part of Immune Reconstitution Inflammatory Syndrome due to Chronic Disseminated Candidiasis in a Child With Acute Lymphoblastic leukemia.
Reddy NA; Addala S; S S S; Lashkari HP
J Pediatr Hematol Oncol; 2023 May; 45(4):e555-e559. PubMed ID: 37083275
[TBL] [Abstract] [Full Text] [Related]
11. Chronic Disseminated Candidiasis in Children and the Role of Corticosteroids Therapy.
Al Yazidi LS; Elsidig N; Wali Y; Nazir H
Pediatr Infect Dis J; 2023 May; 42(5):e146-e151. PubMed ID: 36795580
[TBL] [Abstract] [Full Text] [Related]
12. Risks and outcomes of hospitalizations in patients with chronic lymphocytic leukemia admitted with immune thrombocytopenia: an analysis of the National Inpatient Sample Database.
Ammad Ud Din M; Mahmud A; Mostafa M; Shahzad M; Liaqat H; Pinilla-Ibarz J; Jaglal M
Ann Hematol; 2023 Apr; 102(4):889-895. PubMed ID: 36781419
[TBL] [Abstract] [Full Text] [Related]
13. Low Expression of brca1 as a Potential Relapse Predictor in B-Cell Acute Lymphoblastic leukemia.
Villegas-Ruíz V; Medina-Vera I; Arellano-Perdomo P; Castillo-Villanueva A; Galván-Diaz CA; Paredes-Aguilera R; Rivera-Luna R; Juárez-Méndez S
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e167-e173. PubMed ID: 36730467
[TBL] [Abstract] [Full Text] [Related]
14. Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours.
Barszczewska-Pietraszek G; Drzewiecka M; Czarny P; Skorski T; Śliwiński T
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613762
[TBL] [Abstract] [Full Text] [Related]
15. Wee1 promotes cell proliferation and imatinib resistance in chronic myeloid leukemia via regulating DNA damage repair dependent on ATM-γH2AX-MDC1.
Zeng F; Peng Y; Qin Y; Wang J; Jiang G; Feng W; Yuan Y
Cell Commun Signal; 2022 Dec; 20(1):199. PubMed ID: 36575478
[TBL] [Abstract] [Full Text] [Related]
16. Synergistic effect of combined PI3 kinase inhibitor and PARP inhibitor treatment on BCR/ABL1-positive acute lymphoblastic leukemia cells.
Hiroki H; Akahane K; Inukai T; Morio T; Takagi M
Int J Hematol; 2023 May; 117(5):748-758. PubMed ID: 36575328
[TBL] [Abstract] [Full Text] [Related]
17. Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut Microbiome.
Zargari Marandi R; Jørgensen M; Ilett EE; Nørgaard JC; Noguera-Julian M; Paredes R; Lundgren JD; Sengeløv H; MacPherson CR
Cells; 2022 Dec; 11(24):. PubMed ID: 36552852
[TBL] [Abstract] [Full Text] [Related]
18. Differentially Expressed Cell Cycle Genes and STAT1/3-Driven Multiple Cancer Entanglement in Psoriasis, Coupled with Other Comorbidities.
Dorai S; Alex Anand D
Cells; 2022 Nov; 11(23):. PubMed ID: 36497125
[TBL] [Abstract] [Full Text] [Related]
19. [BILATERAL OCULAR PLASMACYTOMA PRESENTING AS ACUTE ANTERIOR UVEITIS].
Sharon Y; Reich E; Hayman L; Kramer M
Harefuah; 2022 Oct; 161(10):606-610. PubMed ID: 36315206
[TBL] [Abstract] [Full Text] [Related]
20. BMI-1 promotes breast cancer proliferation and metastasis through different mechanisms in different subtypes.
Liu JY; Jiang YN; Huang H; Xu JF; Wu YH; Wang Q; Zhu Y; Zheng B; Shen C; Qian WF; Shen J
Cancer Sci; 2023 Feb; 114(2):449-462. PubMed ID: 36285479
[TBL] [Abstract] [Full Text] [Related]
[Next]
